Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:1937-1943

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyriakides, Z. S.
Right arrow Articles by Webb, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyriakides, Z. S.
Right arrow Articles by Webb, D. J.
Related Collections
Right arrow Receptor pharmacology

(Circulation. 2000;102:1937.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Acute Endothelin-A Receptor Antagonism Prevents Normal Reduction of Myocardial Ischemia on Repeated Balloon Inflations During Angioplasty

Zenon S. Kyriakides, MD; Dimitrios Th. Kremastinos, MD; Theofilos M. Kolettis, MD; Androniki Tasouli, MD; Aias Antoniadis, MD; David J. Webb, MD

From the Second Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece (Z.S.K., D.T.K., T.M.K., A.T., A.A.), and the Department of Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK (D.J.W.).

Correspondence to Zenon S. Kyriakides, MD, Onassis Cardiac Surgery Center, 356 Sygrou Ave, GR-17674 Athens, Greece. E-mail zskyr{at}otenet.gr

Background—Myocardial ischemia and reperfusion are associated with increased production of endothelin (ET)-1.

Methods and Results—We examined the effects of BQ-123, a selective ETA receptor antagonist, in 80 patients. All patients were randomly allocated to an intracoronary infusion of saline or BQ-123 (6 µmol/L over 20 minutes). The reference group consisted of 20 patients undergoing coronary angiography. BQ-123 produced a 10% (P<0.005) increase in distal coronary artery diameter. The main study group consisted of 30 patients undergoing coronary angioplasty. All patients underwent a minimum of 3 balloon inflations (BIs). Surface and intracoronary electrocardiographic ST-segment shift as well as pain score were recorded at the end of each BI. BQ-123 or saline was given by intracoronary infusion between the second and the third BI in random allocation. In the saline group, intracoronary ST-elevation decreased from 1.26±0.55 mV during the first BI to 0.77±0.56 mV during the third BI (P<0.05) and the surface ST elevation decreased from 0.20±0.15 to 0.10±0.07 mV (P<0.05). In the BQ-123 group, the respective values were 1.22±0.48 mV and 1.13±0.62 mV (intracoronary) and 0.17±0.18 and 0.17±0.21 mV (surface) (both P=NS). The decrease in pain score was significantly higher in the saline group (F=5.97, P=0.004). In 30 patients (collateral circulation group), the angioplasty protocol was repeated with the use of a pressure guide wire. BQ-123 produced a significant (F=3.30, P=0.04) decrease in coronary wedge pressure.

Conclusions—Acute ETA receptor antagonism prevents the normal reduction of myocardial ischemia on repeated BIs during angioplasty. This may be explained by a "steal" effect through coronary collaterals.


Key Words: endothelin • ischemia • angioplasty




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
K. A. Apple, J. E. McLean, C. E. Squires, B. Schaeffer, J. A. Sample, R. L. Murphy, A. M. Deschamps, A. H. Leonardi, C. M. Allen, J. W. Hendrick, et al.
Differential Effects of Protein Kinase C Isoform Activation in Endothelin-Mediated Myocyte Contractile Dysfunction With Cardioplegic Arrest and Reperfusion
Ann. Thorac. Surg., August 1, 2006; 82(2): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. G. Baltogiannis, D. G. Tsalikakis, A. C. Mitsi, K. E. Hatzistergos, D. Elaiopoulos, D. I. Fotiadis, Z. S. Kyriakides, and T. M. Kolettis
Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats
Cardiovasc Res, September 1, 2005; 67(4): 647 - 654.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
Z. S. Kyriakides, S. Psychari, E. K. Iliodromitis, T. M. Kolettis, E. Sbarouni, and D. T. Kremastinos
Hyperlipidemia Prevents the Expected Reduction of Myocardial Ischemia on Repeated Balloon Inflations During Angioplasty*
Chest, April 1, 2002; 121(4): 1211 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. V Agapitov and W. G Haynes
Role of endothelin in cardiovascular disease
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 1 - 15.
[Abstract] [PDF]


Home page
HeartHome page
Z S Kyriakides, S Psychari, N Chrysomallis, M Georgiadis, E Sbarouni, and D T Kremastinos
Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty
Heart, January 1, 2002; 87(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P.J. Cowburn and J.G.F. Cleland
Endothelin antagonists for chronic heart failure: do they have a role?
Eur. Heart J., October 1, 2001; 22(19): 1772 - 1784.
[PDF]